MarketInOut Stock Screener Log In | Sign Up

Innovacell Inc

TSE • Healthcare • Biotechnology • Quote as of 10/28/2026 15:30
Innovacell Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeTSE
Market Capitalization21,131 mln
Float20.67 mln

Piotroski F-Score

4 / 9
Borderline

Relative Strength

14 / 100
Significantly lagging

Debt / Equity

0.23
Very low leverage

Pre-Tax Margin

-19,628%
Severely loss-making

ROE

-67.17
Deeply negative

ROA

-36.45
Deeply negative

Business Description

Innovacell Inc. is a Japanese biotechnology company founded in 2021 and headquartered in Shinagawa, Japan. The company focuses on developing and producing cell-based treatments for conditions that affect bladder and bowel control, including stress urinary incontinence and two forms of fecal incontinence. Its current product lineup consists of three therapies: ICEF15, ICEF16, and ICES13.

Key Fundamentals

EPS-98.99
ROE-67.17
RPS0.43
ROIC-230
ROA-36.45
EBITDA, mln-2,380
EV / EBITDA-8.32
EV / EBIT-8.08
Revenue, mln16.61
EV / Revenue1,192

Quote Details

Last 505.00
Change 43 (9.31%)
Open 466.00
Volume 174,200
Turnover 87,971,000
Average Volume 87,724

Financial Ratios

Pre-Tax Profit Margin-19,628
Current Ratio24.75
Price / Book2.99
Price / Tangible Book3.00
Debt / Equity0.23
Price / Sales1,717

Financial Strength

Piotroski F-Score 4 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.17% 46 / 100   
1 Month -15.27% 7 / 100   
2 Months 6.09% 73 / 100   
6 Months -28.37% 7 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog